IN2013MU03421A - - Google Patents
Info
- Publication number
- IN2013MU03421A IN2013MU03421A IN3421MU2013A IN2013MU03421A IN 2013MU03421 A IN2013MU03421 A IN 2013MU03421A IN 3421MU2013 A IN3421MU2013 A IN 3421MU2013A IN 2013MU03421 A IN2013MU03421 A IN 2013MU03421A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutically acceptable
- acceptable derivative
- sulbactam
- cefepime
- stereoisomer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3421MU2013 IN2013MU03421A (enExample) | 2013-10-30 | 2014-10-30 | |
| EP14811971.2A EP3062794B1 (en) | 2013-10-30 | 2014-10-30 | Pharmaceutical compositions comprising antibacterial agents |
| US15/030,061 US20160271118A1 (en) | 2013-10-30 | 2014-10-30 | Pharmaceutical compositions comprising antibacterial agents |
| PCT/IB2014/065708 WO2015063714A1 (en) | 2013-10-30 | 2014-10-30 | Pharmaceutical compositions comprising antibacterial agents |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3421MU2013 IN2013MU03421A (enExample) | 2013-10-30 | 2014-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03421A true IN2013MU03421A (enExample) | 2015-07-17 |
Family
ID=52023565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3421MU2013 IN2013MU03421A (enExample) | 2013-10-30 | 2014-10-30 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20160271118A1 (enExample) |
| EP (1) | EP3062794B1 (enExample) |
| IN (1) | IN2013MU03421A (enExample) |
| WO (1) | WO2015063714A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108602822A (zh) * | 2015-12-11 | 2018-09-28 | 沃克哈特有限公司 | 含有7-氧代-6-(硫氧基)-1,6-二氮杂双环[3.2.1]辛烷-2-甲酰胺的化合物及其在治疗细菌感染中的用途 |
| KR102354697B1 (ko) * | 2017-03-02 | 2022-01-21 | 욱크하르트 리미티드 | 항박테리아 화합물로서의 헤테로고리 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2842777C (en) * | 2011-07-26 | 2015-12-29 | Wockhardt Limited | Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor |
| US8796257B2 (en) * | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| ES2672100T3 (es) * | 2012-08-25 | 2018-06-12 | Wockhardt Limited | Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona y su uso en el tratamiento de infecciones bacterianas |
-
2014
- 2014-10-30 WO PCT/IB2014/065708 patent/WO2015063714A1/en not_active Ceased
- 2014-10-30 EP EP14811971.2A patent/EP3062794B1/en not_active Not-in-force
- 2014-10-30 IN IN3421MU2013 patent/IN2013MU03421A/en unknown
- 2014-10-30 US US15/030,061 patent/US20160271118A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3062794A1 (en) | 2016-09-07 |
| US20160271118A1 (en) | 2016-09-22 |
| WO2015063714A1 (en) | 2015-05-07 |
| EP3062794B1 (en) | 2018-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500591B1 (en) | Heterocyclic compounds and uses thereof | |
| NZ739676A (en) | Heteroaryl compounds as irak inhibitors and uses thereof | |
| TW201613911A (en) | Heterocyclic compounds and uses thereof | |
| PH12015501996B1 (en) | Heterocyclic compounds and uses thereof | |
| PH12018500061A1 (en) | Oxysterols and methods of use thereof | |
| MX2018001990A (es) | Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac. | |
| JO3452B1 (ar) | بنزاميدات أمينو اريل مغاير كمثبطات كيناز | |
| TN2015000519A1 (en) | Small molecule inhibitors of fibrosis | |
| JO3425B1 (ar) | مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b | |
| MX2016013431A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX2018014813A (es) | Composiciones antibacterianas. | |
| MX2015015562A (es) | Dihidropiridinona como inhibidores de monoacilglicerol aciltransferasa 2. | |
| PH12017502319A1 (en) | Injectable pharmaceutical formulations of lefamulin | |
| MX2016001138A (es) | Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo. | |
| TW201613898A (en) | Benzofuran analogue as NS4B inhibitor | |
| IN2014MU00859A (enExample) | ||
| IN2013MU03308A (enExample) | ||
| IN2013MU03422A (enExample) | ||
| IN2013MU03704A (enExample) | ||
| IN2013MU03309A (enExample) | ||
| MX2016013428A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| IN2014MU01194A (enExample) | ||
| IN2013MU03565A (enExample) | ||
| MX2017010992A (es) | Composiciones farmaceuticas estables que comprenden agente antibacteriano. | |
| MX2018010652A (es) | Composiciones farmaceuticas. |